Metraipolis › archive › dc_6ccb4afdb317

Concomitant Comedications and Survival With First-Line Pembrolizumab in Advanced Non-Small-Cell Lung Cancer — Europe PMC PMID:40928782

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40928782
DOI
10.1001/jamanetworkopen.2025.29225
License (as archived)
solo-consultazione
Archived
2026-11-10T04:42:37.493Z
SHA-256 of the archived text
28fac5e3c788cf70c9359f3508864b5422f2262fe6112453169b31975f95d8c9
Stable URL of this page
https://metraipolis.com/documento/dc_6ccb4afdb317

How to cite

Concomitant Comedications and Survival With First-Line Pembrolizumab in Advanced Non-Small-Cell Lung Cancer — Europe PMC PMID:40928782 — Europe PMC (en), https://europepmc.org/article/MED/40928782 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6ccb4afdb317 (Metraipolis archive dc_6ccb4afdb317, sha256 28fac5e3c788cf70c9359f3508864b5422f2262fe6112453169b31975f95d8c9)
BibTeX
@misc{dc6ccb4afdb317,
  title = {Concomitant Comedications and Survival With First-Line Pembrolizumab in Advanced Non-Small-Cell Lung Cancer — Europe PMC PMID:40928782},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40928782},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6ccb4afdb317; sha256 28fac5e3c788cf70c9359f3508864b5422f2262fe6112453169b31975f95d8c9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40928782. Agents can read the archived copy with the MCP tool read_document.